3rd Quarter - Report — BREAKTHROUGH T1D (FORMERLY KNOWN AS JDR… for BREAKTHROUGH T1D (FORMERLY KNOWN AS JDR… (2026)

Firm

BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)

Client

BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)

Income

—

Expenses

$150,000

Expense method

B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

H.R. 8646, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2027; H.R. 9620, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027; Issues pertaining to NIH & FDA funding.

Lobbyist	Covered position, as disclosed
CHRISTINA INGRAM	—
DON LYSTER	—
PEDRO MONTENEGRO	—
LAURA WHITTON	—

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 8646 (119th), H.R. 9620 (119th)

Health Issues HCR

H.R. 10227, the INSULIN Act and Issues pertaining to FDA modernization; S. 4189 - the INSULIN Act; S. 4612/H.R. 9000 - the SCREEN For T1D Act; S. 8270/H.R. 8018 - the ISLET Act; Issues pertaining to cell and gene therapies; Issues pertaining to C-peptide; Issues pertaining to NIH research; Issues pertaining to grant funding for the Special Diabetes Program; Issues pertaining to pending legislation for reclassification of deceased donor islet cells.

Lobbyist	Covered position, as disclosed
CHRISTINA INGRAM	—
DON LYSTER	—
PEDRO MONTENEGRO	—
LAURA WHITTON	—

Contacted: Health Resources & Services Administration (HRSA); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE; Natl Institutes of Health (NIH)

Bills named: S. 4189 (119th), H.R. 9000 (119th), H.R. 8018 (119th), S. 8270 (119th), S. 4612 (119th), H.R. 10227 (119th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.